NCT05553691: SPL026 With or Without SSRIs in Participants With MDD
- State
- Completed
- Phase
- Phase 1
- People
- 18 taking part
- Started
- 13 Dec 2022
- Primary completion
- 3 Aug 2023
- Arms
- Test Cohort, Control Cohort
- Results
- None posted
- 23 Sep 2022: Trial registered
- 13 Dec 2022: Trial started
- 3 Aug 2023: Trial completed